Lifeward Ltd (LFWD) Quarterly and Annual Segment Results by Country and Region - CSIMarket
CSIMarket
 
Lifeward ltd   (NASDAQ: LFWD)

Select the Financial Report: Select the Period:


Description of Lifeward Ltd's Business Segments


ReWalk Robotics Ltd is a pioneering company in the field of robotic exoskeletons, designed to aid individuals with spinal cord injuries and other physical disabilities to regain mobility. The companys offerings can be segmented into various categories, including its products and associated services. Below is a detailed overview of the segments, products, and services provided by ReWalk Robotics.

Products

1. ReWalk Exoskeleton Systems:
- ReWalk Personal System: This is a wearable robotic suit that enables individuals with lower limb disabilities to stand upright, walk, and even climb stairs. The system is comprised of a series of motors and sensors to support movement, allowing users to achieve independent mobility in various settings, including home and community environments.
- ReWalk Rehabilitation System: Designed primarily for clinical settings, this system offers therapists the ability to provide guided training for users in a controlled environment. The rehabilitation system helps facilitate gait training and physiotherapy by using the exoskeleton to mimic natural walking patterns.
- ReWalk Ready: An innovative version of the ReWalk system that focuses on providing users with the technology necessary for integration into their daily lives, emphasizing ease of use and convenience.

2. Accessories and Add-ons:
- To enhance the usability and comfort of the ReWalk systems, the company offers a range of accessories. These may include custom fitting options, upgraded control systems for better responsiveness, and additional support products designed for wearability and comfort during use.

Services

1. Training and Support:
- ReWalk Robotics provides comprehensive training programs for users to ensure they can operate the exoskeleton safely and effectively. This may include sessions with certified trainers, ongoing support, and adjustments based on user feedback to enhance usability.

2. Clinical Partnerships:
- By collaborating with rehabilitation facilities and healthcare providers, ReWalk Robotics facilitates research and implementation of their systems. This is aimed at ensuring users receive the best therapeutic benefits from their exoskeletons during rehabilitation sessions.

3. User Community Engagement:
- The company actively fosters a community among its users, offering platforms for sharing experiences, tips, and personal stories. This engagement helps build a support network for users and promotes motivation and empowerment.

4. Technical Support and Maintenance:
- ReWalk Robotics provides ongoing technical support to users, including troubleshooting and maintenance services to ensure the exoskeleton systems function optimally. This could involve routine check-ups, software updates, and repair services conducted by trained professionals.

Clinical and Research Initiatives

ReWalk Robotics is also involved in various clinical trials and research studies aimed at evaluating the effectiveness of robotic rehabilitation technologies. This includes collaborations with hospitals and research institutions to assess outcomes related to physical rehabilitation and quality of life improvements for users of their exoskeleton systems.

Market and Impact

ReWalk Robotics has made substantial impacts in the lives of individuals with mobility challenges. By enabling greater independence and fostering a sense of normalcy, their innovative products not only assist users in regaining physical mobility but also promote psychological well-being. Their technology serves diverse populations, including military veterans and civilians affected by spinal cord injuries, and is recognized for its contributions to advancing mobility solutions in rehabilitation science.

In conclusion, ReWalk Robotics Ltd stands at the forefront of innovation in mobility assistance, offering a comprehensive suite of products and services designed to empower individuals with mobility impairments. Their dedication to enhancing the quality of life through advanced robotic solutions positions them as a key player in the field of medical robotics and rehabilitation technology.


Composition of Lifeward ltd Revenues by Segments

 
Product    126.89 % of total Revenue
Europe    20.38 % of total Revenue
US    97 % of total Revenue
United States    27.65 % of total Revenue
Rest Of World    3.73 % of total Revenue

Q2 three months ended (Jun 30 2026)
Revenues by Business Segments Revenues
(in millions $)
%
(of total Revenues)
Product 8.40 126.89 %
Europe 1.35 20.38 %
US 6.42 97 %
United States 1.83 27.65 %
Rest Of World 0.25 3.73 %
Total 6.62 100 %




Q2 three months ended (Jun 30 2026)
Revenue Growth rates by Segment Y/Y Revenue
%
Q/Q Revenue
%
Product - -
Europe -35.81 % 93.69 %
US - -
United States -40.2 % -22.45 %
Rest Of World -43.22 % 126.61 %
Total 15.71 % 68.82 %




Q2 three months ended (Jun 30 2026)
Income by Business Segments Income
(in millions $)
%
(Profit Margin)
Total -11.52 -




Q2 three months ended (Jun 30 2026)
Income Growth rates by Segment Y/Y Income
%
Q/Q Income
%
Total - -




Annual Report on Lifeward ltd Divisions, Sales by Country

 
Europe   Europe Segment contribution to total sales 13.19 % of total Revenue
Rest Of World   Rest Of World Segment contribution to total sales 6.43 % of total Revenue
Germany   Germany Segment contribution to total sales 18.22 % of total Revenue
Asia Pacific   Asia Pacific Segment contribution to total sales 2.09 % of total Revenue
UNITED STATES   UNITED STATES Segment contribution to total sales 60.08 % of total Revenue


Twelve months ended 2025
LFWD s Annual Revenue by Geography and Business Segments Sales
(in millions $)
%
(of total Sales)
Europe 2.91 13.19 %
Rest Of World 1.42 6.43 %
Total 22.03 100 %
Germany 4.01 18.22 %
Asia Pacific 0.46 2.09 %
UNITED STATES 13.24 60.08 %


Twelve months ended 2025
LFWD s Annual Income by Country and Business Segments Income
(in millions $)
%
(Profit Margin)
Total -19.91 -

Twelve months ended 2025
Annual Revenue and Income Growth by Country and Business Segments % Y/Y Sales Growth % Y/Y Income Growth
Europe -43.27 % -
United States - -
Rest Of World 63.32 % -
Total -14.14 % -
Germany -9.23 % -
Asia Pacific -44.24 % -



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.